DiaMedica Therapeutics Inc. Common Stock

$9.99
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.51 (+5.43%) Today
+$0.08 (+0.81%) As of 12:00 AM UTC after-hours

Why Robinhood?

You can buy or sell DMAC and other stocks, options, and ETFs commission-free!

About DMAC

DiaMedica Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the development of novel recombinant proteins. It develops the DM199 product candidate, which focuses on acute ischemic stroke (AIS) and chronic kidney disease (CKD).

CEO
Rick John Pauls
Employees
11
Headquarters
Minneapolis, Minnesota
Founded
2000
Market Cap
187.85M
Price-Earnings Ratio
Dividend Yield
Average Volume
83.87K
High Today
$10.13
Low Today
$9.65
Open Price
$9.65
Volume
323.52K
52 Week High
$10.88
52 Week Low
$2.88

DMAC Earnings

-$0.23
-$0.15
-$0.08
$0.00
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
per share
Actual
Expected May 12, After Hours

You May Also Like

JCTR
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure